ArticleBiophotonics discovery2025
Optical phenotyping using label-free microscopy and deep learning.
Article in Biophotonics discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Artificial Intelligence for Discovery in Life Sciences.Bioconjugate chemistry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Significance: Tissue phenotyping plays a critical role in biomedical research and clinical applications by providing insight into the structural and functional characteristics of tissues that can characterize clinical behavior and identify therapeutic targets. However, conventional phenotyping techniques are destructive, time-intensive, and expensive, posing challenges for both efficiency and widespread use. Aim: We aim to develop an optical phenotyping approach in pancreatic cancer specimens using label-free multiphoton microscopy combined with spatial transcriptomics and deep learning. Approach: We measure and co-register a dataset comprised of spatial transcriptomics, autofluorescence, and second harmonic generation microscopy. We then cluster tissue subregions into meaningful phenotypes using transcriptomic signatures. We evaluate three different classification models to predict phenotype based on label-free imaging data, and we assess generalizability and prediction accuracy. Result: Our deep-learning classification model achieves over 89% accuracy in classifying six tissue types using label-free microscopy images. The one-versus-rest area under the curve (AUC) values for all classes approach 1, confirming the robustness of our model. Conclusion: We demonstrate the feasibility of optical phenotyping in distinguishing the structural and functional characteristics of pancreatic cancer specimens. Integrating additional gene-expression data or complementary label-free imaging modalities, such as fluorescence lifetime imaging microscopy, holds the potential to further enhance its accuracy and expand its applications in clinical research and diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.